SC 13D

Company

UroGen Pharma Ltd.

Filed

August 4, 2023

Accession Number

0001140361-23-037975

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →